| Conţinutul numărului revistei |
| Articolul precedent |
| Articolul urmator |
 261 0 |
 SM ISO690:2012SGHIBNEVA-BOBEICO, Nina, TOMACINSCHII, Victor. Clinical Aspects of Idiopathic Myelofibrosis in Young Patients in the Republic of Moldova. In: Clinical Lymphoma, Myeloma and Leukemia, 2019, nr. S1(19), p. 0. ISSN 2152-2650. DOI: https://doi.org/10.1016/j.clml.2019.07.361 |
| EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
 Clinical Lymphoma, Myeloma and Leukemia |
||||||
| Numărul S1(19) / 2019 / ISSN 2152-2650 /ISSNe 2152-2669 | ||||||
|
||||||
| DOI:https://doi.org/10.1016/j.clml.2019.07.361 | ||||||
| Pag. 0-0 | ||||||
|
||||||
| Rezumat | ||||||
Idiopathic myelofibrosis (IM) presents one of several myeloproliferative disorders that originate in the clonal expansion of a single hematopoietic multipotential cell reprogrammated by several somatic mutations and characterized by splenomegaly and hepatomegaly, bone marrow fibrosis and extramedullary hematopoiesis. IM characteristically occurs after age 50 and very rarely in children and young patients. There are 297 patients aged 18 to 92 in the Republic of Moldova. Patients diagnosed with MI aged 18 to 40 years are 35. |
||||||
|
|
|
|
